Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Xeris Biopharma Holdings
XERS
$1.45B
| $649K | ﹤0.01% |
275,963
+170,220
| +161% | +$314K |
|
3627
MaxCyte
MXCT
$126M
| $648K | ﹤0.01% |
137,831
+106,266
| +337% | +$414K |
|
3628
CALL
iShares US Medical Devices ETF
IHI
$3.38B
| $648K | ﹤0.01% |
+12,000
| New | +$586K |
|
|
SILK
3629
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $647K | ﹤0.01% |
52,761
+38,826
| +279% | +$364K |
|
3630
Sunoco
SUN
$13.3B
| $645K | ﹤0.01% |
10,765
-2
| -0% | -$106 |
|
3631
CNB Financial Corp
CCNE
$1.03B
| $645K | ﹤0.01% |
28,543
+21,867
| +328% | +$438K |
|
3632
Heritage Insurance Holdings
HRTG
$991M
| $644K | ﹤0.01% |
98,814
+39,870
| +68% | +$275K |
|
3633
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $643K | ﹤0.01% |
+15,032
| New | +$602K |
|
|
HLVX
3634
DELISTED
HilleVax
HLVX
| $641K | ﹤0.01% |
39,908
+33,534
| +526% | +$446K |
|
3635
First Bancorp
FNLC
$399M
| $640K | ﹤0.01% |
22,663
+11,764
| +108% | +$292K |
|
|
ZIMV
3636
DELISTED
ZimVie
ZIMV
| $637K | ﹤0.01% |
35,910
+30,964
| +626% | +$312K |
|
3637
Western New England Bancorp
WNEB
$275M
| $636K | ﹤0.01% |
70,644
+29,806
| +73% | +$227K |
|
|
ZYXI
3638
DELISTED
Zynex
ZYXI
| $635K | ﹤0.01% |
58,356
-33,473
| -36% | -$298K |
|
|
AAN
3639
DELISTED
The Aaron's Company Inc
AAN
| $635K | ﹤0.01% |
58,354
-19,646
| -25% | -$182K |
|
3640
CALL
Lockheed Martin
LMT
$136B
| $635K | ﹤0.01% |
1,400
-1,400
| -50% | -$620K |
|
3641
Madison Square Garden
MSGS
$9.39B
| $634K | ﹤0.01% |
3,488
-2,879
| -45% | -$499K |
|
3642
NET Power
NPWR
$134M
| $634K | ﹤0.01% |
+62,747
| New | +$753K |
|
3643
CarParts.com
PRTS
$54.7M
| $632K | ﹤0.01% |
19,999
+11,354
| +131% | +$384K |
|
3644
CALL
Immunovant
IMVT
$8.25B
| $632K | ﹤0.01% |
15,000
+600
| +4% | +$22.1K |
|
|
3645
PUT
Immunovant
IMVT
$8.25B
| $632K | ﹤0.01% |
+15,000
| New | +$552K |
|
|
INFA
3646
DELISTED
Informatica
INFA
| $631K | ﹤0.01% |
22,212
-1,403
| -6% | -$33.7K |
|
3647
AnaptysBio
ANAB
$1.68B
| $628K | ﹤0.01% |
29,308
-6,761
| -19% | -$117K |
|
|
SEI
3648
Solaris Energy Infrastructure
SEI
$3.82B
| $627K | ﹤0.01% |
78,796
+37,737
| +92% | +$341K |
|
3649
Harrow
HROW
$1.51B
| $625K | ﹤0.01% |
55,815
+19,951
| +56% | +$236K |
|
3650
Savers
SVV
$1.88B
| $625K | ﹤0.01% |
35,968
+31,147
| +646% | +$471K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.